⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4965571 | 1.00 | CA2 (0.47) | — | |
| SCHEMBL221388 | 1.00 | — | — | |
| SCHEMBL23556 | 1.00 | — | — | |
| SCHEMBL9423852 | 0.98 | CA2 (0.46) | — | |
| Ammonia Solution, Strong SCHEMBL21775798 | 0.98 | CA2 (0.46) | — | |
| SCHEMBL9423640 | 0.98 | CA2 (0.46) | — | |
| SCHEMBL9423643 | 0.98 | CA2 (0.46) | — | |
| Alcohol SCHEMBL9421490 | 0.96 | CA2 (0.44) | — | |
| Acetic Acid SCHEMBL15955948 | 0.92 | CA2 (0.46) | — | |
| Dimethyl Sulfoxide SCHEMBL9985869 | 0.90 | CA2 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250236633-A1 | SYNTHESIS OF ISOMERICALLY PURE POLYOL-BASED PHOSPHORAMIDITES | Roche Sequencing Solutions, Inc. (US) | 2025-07-24 | — | — | US | claimed |
| EP-4499655-A1 | SYNTHESIS OF ISOMERICALLY PURE POLYOL-BASED PHOSPHORAMIDITES | F. Hoffmann-La Roche AG (CH) | 2025-02-05 | — | — | EP | claimed |
| CN-117143145-A | Preparation method of dioleoyl phosphatidylethanolamine | 安徽昊帆生物有限公司 | 2023-12-01 | — | — | CN | claimed |
| WO-2023186842-A1 | SYNTHESIS OF ISOMERICALLY PURE POLYOL-BASED PHOSPHORAMIDITES | F. HOFFMANN-LA ROCHE AG (CH) | 2023-10-05 | — | — | WO | claimed |
| CN-113999259-A | Preparation method of (R) -glycerolphosphinyl-N-Boc ethanolamine sodium salt | 苏州昊帆生物股份有限公司 | 2022-02-01 | — | — | CN | claimed |
| EP-1468007-A2 | PSEUDONUCLEOTIDE COMPRISING AN INTERCALATOR | Human Genetic Signatures PTY Ltd. (AU) | 2004-10-20 | — | — | EP | claimed |
| US-6794529-B2 | CATALYTIC REACTION OF DIBORANE COMPOUND USING GROUP 8 METAL CATALYST | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2004-09-21 | — | — | US | claimed |
| WO-2003051901-A2 | PSEUDONUCLEOTIDE COMPRISING AN INTERCALATOR | HUMAN GENETIC SIGNATURES PTY LTD (AU) | 2003-06-26 | — | — | WO | claimed |
| EP-0965268-B1 | Thermostabilization, osmoprotection, and protection against desiccation of enzymes, cell components and cells by di-glycerol-phosphate | BITOP AG (DE) | 2003-03-19 | — | — | EP | claimed |
| EP-0965268-A1 | Thermostabilization, osmoprotection, and protection against desiccation of enzymes, cell components and cells by di-glycerol-phosphate | IBET - Instituto de Biologia Experimental e Tecnologica (PT) | 1999-12-22 | — | — | EP | claimed |
| US-5047563-A | Ionophores | MILES INC. (US) | 1991-09-10 | — | — | US | claimed |
| WO-1990009981-A1 | PREPARATION OF OPTICALLY ACTIVE GLYCEROL DERIVATIVES | ISIS INNOVATION LIMITED (GB) | 1990-09-07 | — | — | WO | claimed |
| US-4326076-A | Method for preparing the optically active isomer of 2,2-[[5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-1,2,3,4-tetrahydro-2,3-naphthalene-diyl]bis(oxy)]bis[N,N-dipropylacetamide] | E. R. SQUIBB & SONS, INC. (US) | 1982-04-20 | — | — | US | claimed |
| US-12630566-B2 | KRas G12D inhibitors | Mirati Therapeutics, Inc. (US) | 2026-05-19 | — | — | US | disclosed |
| US-20260097111-A1 | ETHER LIPIDS FOR HYPERACTIVATION OF MAMMALIAN DENDRITIC CELLS | CORNER THERAPEUTICS, INC. (US) | 2026-04-09 | — | — | US | disclosed |
| US-12594292-B2 | Antiviral prodrugs, intermediate-and long-acting formulations and methods | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-04-07 | — | — | US | disclosed |
| US-4350812-A | Antiarrhythmic tetrahydronaphthalene derivatives | E. R. SQUIBB & SONS, INC. (US) | 1982-09-21 | — | — | US | disclosed |
| US-4326076-A | Method for preparing the optically active isomer of 2,2-[[5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-1,2,3,4-tetrahydro-2,3-naphthalene-diyl]bis(oxy)]bis[N,N-dipropylacetamide] | E. R. SQUIBB & SONS, INC. (US) | 1982-04-20 | — | — | US | disclosed |
| US-4302453-A | Antiarrhythmic tetrahydronaphthalene derivatives | E. R. SQUIBB & SONS, INC. (US) | 1981-11-24 | — | — | US | disclosed |
| EP-0028940-A1 | Antiarrhythmic tetrahydronaphthalene derivatives | E.R. Squibb & Sons, Inc. (US) | 1981-05-20 | — | — | EP | disclosed |